Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Oxford Biomedica chair ups stake

Thu 24 Sep 2026 09:19

(Sharecast News) - The largest market purchase of shares in London on Thursday came from Oxford Biomedica's chair Roch Doliveux. who upped his stake in the cell and gene therapy company after a sharp drop in the stock over the year to date. Doliveux, has been at the helm of the board since 2020, bought 20,250 shares at a price of 505p each, spending a total of £102,262.50.

OXB's share price closed Wednesday's session at 481p, having lost over a quarter of its value since the start of 2026.

After the latest purchase, Oxford Biomedica said Doliveux owns 459,055 shares, equivalent to 0.379% of the company's issued share capital.

Top Director Buys

Oxford Biomedica (OXB) Director name: Doliveux,Roch Amount purchased: 20,250 @ 505.00p Value: £102,262.50

St James's Place (STJ) Director name: Manduca,Paul Amount purchased: 3,624 @ 1,097.73p Value: £39,781.55

St James's Place (STJ) Director name: Manduca,Paul Amount purchased: 3,624 @ 1,097.73p Value: £39,781.55

Trufin (TRU) Director name: Bergh,James van den Amount purchased: 30,000 @ 97.57p Value: £29,271.00

Gresham House Energy Storage Fund (GRID) Director name: Stevenson ,David Amount purchased: 8,610 @ 98.10p Value: £8,446.41

Activeops (AOM) Director name: Jeffery,Richard John Amount purchased: 73 @ 205.00p Value: £149.65

St James's Place (STJ) Director name: FitzPatrick,Mark Amount purchased: 4 @ 1,125.23p Value: £45.01

St James's Place (STJ) Director name: Manduca,Paul Amount purchased: 2 @ 1,125.23p Value: £22.50

Share this article

Related Sharecast Articles

Fri 02 Oct 2026 14:16
Director dealings: Symphony International Holdings director continues to buy
(Sharecast News) - A director of Asia-focused investment company Symphony International Holdings continued to ramp up his investment in the company on Friday, purchasing a further $200,000 of shares.
Thu 01 Oct 2026 12:43
Director dealings: Checkit CEO snaps up shares
(Sharecast News) - Checkit revealed on Thursday that chief executive Kit Kyte had acquired 618,745 ordinary shares in the AIM-listed automated monitoring platform operator.
Wed 30 Sep 2026 14:52
Director dealings: Sysgroup non-executive director raises stake
(Sharecast News) - Sysgroup revealed on Wednesday that non-executive director Michael Fletcher had acquired 77,623 ordinary shares in the AIM-listed managed technology partner.
Tue 29 Sep 2026 12:40
Director dealings: Midwich CFO takes up stake
(Sharecast News) - Midwich revealed on Tuesday that chief financial officer Adam Councell had acquired 74,586 ordinary shares in the AIM-listed technology solutions provider.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statements | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026